Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild‐type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial
Year: 2025
Type: article
Language: en
Topic: Glioma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Jing Zhang
raw_affiliation_strings: Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Peng Wang
raw_affiliation_strings: Department of Molecular Neuropathology Beijing Neurosurgical Institute Capital Medical University  Beijing China
Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
raw_author_name: Yin Ren
raw_affiliation_strings: Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Li Chen
raw_affiliation_strings: Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Jin Feng
raw_affiliation_strings: Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Fei Liu
raw_affiliation_strings: Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Kaiwen Deng
raw_affiliation_strings: Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Zhaoshi Bao
raw_affiliation_strings: Department of Molecular Neuropathology Beijing Neurosurgical Institute Capital Medical University  Beijing China
Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
raw_author_name: Xiaoguang Qiu
raw_affiliation_strings: Department of Molecular Neuropathology Beijing Neurosurgical Institute Capital Medical University  Beijing China
Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
National Clinical Research Center for Neurological Diseases  Beijing China
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
National Clinical Research Center for Neurological Diseases, Beijing, China
raw_author_name: Yanwei Liu
raw_affiliation_strings: Department of Molecular Neuropathology Beijing Neurosurgical Institute Capital Medical University  Beijing China
Department of Radiation Oncology Beijing Tiantan Hospital Capital Medical University  Beijing China
Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China